Francesca Briganti

Has grant

Assistant Professor

UCSD

United States

Research Interests

Explore related searches

Professors in United States Professors in Tissue Engineering Tissue Engineering professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Francesca Briganti is an Assistant Professor at the University of California, San Diego (UCSD), USA. Her research primarily focuses on cardiac physiology and pathology, with recent articles exploring alternative splicing in the heart, human iPSC modeling of heart disease, and the therapeutic potential of targeting RBM20 in cardiomyocytes. She is particularly interested in the regulation of transcriptional and epigenetic mechanisms in cardiovascular disease.

Recent Grants

Grant: Close

Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy

Open Date: 2023-07-14

Close Date: 2025-06-30

Articles (9)

Year:

2024

Year:

2024

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Ioannis Karakikes

Assistant Professor

Stanford University

UNITED STATES

View details

Chi Keung Lam

Assistant Professor

University of Delaware

UNITED STATES

View details

Wei Guo

University of Wisconsin-Madison

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesca Briganti

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (9)

Alternative Splicing in the Heart: The Therapeutic Potential of Regulating the Regulators

Transcriptional and epigenetic characterization of a new in vitro platform to model the formation of human pharyngeal endoderm

Author Correction: Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs

Abstract 14462: RBM20 Regulation In Healthy And Diseased Cardiomyocytes: A New Opportunity For Targeted Therapeutics

Human iPSC modeling of heart disease for drug development

Single-molecule, full-length transcript isoform sequencing reveals disease-associated RNA isoforms in cardiomyocytes

Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes.

iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy.

Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs

Collaborators (3)

Ioannis Karakikes

Chi Keung Lam

Wei Guo

Make your next move.